The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients

Transfusion

Volumn 47, Issue 4, 2007, Pages 573-581

  Blumberg, Neil ^a   Zhao, Hongwei ^b   Wang, Hongkun ^b   Messing, Susan ^b   Heal, Joanna M ^b   Lyman, Gary H ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; HUMAN; LEUKAPHERESIS; MEDICAL LITERATURE; POSTOPERATIVE INFECTION; SCIENTIFIC LITERATURE; STATISTICAL ANALYSIS; SURGICAL PATIENT; VALIDITY;

BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS;

EID: 33947393468     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01158.x     Document Type: Article

References (33)

1. Kunz R, Guyatt G. Which patients to include in the analysis? Transfusion 2006;46:881-4.
2. Fergusson D, Aaron SD, Guyatt G, Hebert P. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis. BMJ 2002;325:652-4.
3. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 2005;45:33S-39S; discussion 39S-40S.
4. Vamvakas EC. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt. Transfusion 2006;46:492-4; author reply 494-5.
5. Blumberg N. Deleterious clinical effects of transfusion immunomodulation: proven beyond a reasonable doubt (author's reply). Transfusion 2006;46:494-5.
6. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
7. Sutton A, Abrams K, Jones D, Sheldon T, Song F. Methods for meta-analysis in medical research. London: Wiley; 2000.
8. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
9. Houbiers JG, Brand A, van de Watering LM, et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573-8.
10. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996;348:841-5.
11. Tartter PI, Mohandas K, Azar P, et al. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998;176:462-6.
12. van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery - a randomized clinical trial. Circulation 1998;97:562-8.
13. Titlestad IL, Ebbesen LS, Ainsworth AP, et al. Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications - results of a double-blinded, randomized study. Int J Colorectal Dis 2001;16:147-53.
14. Wallis JP, Chapman CE, Orr KE, Clark SC, Forty JR. Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002;42:1127-34.
15. Bilgin YM, van deWatering LM, Eijsman L, et al. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004;109:2755-60.
16. van Hilten JA, van de Watering LM, van Bockel JH, et al. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. BMJ 2004;328:1281.
17. Vamvakas E, Blajchman M. A proposal for an individual patient data based meta-analysis of randomized controlled trials of allogeneic transfusion and postoperative bacterial infection. Transfus Med Rev 1997;11:180-94.
18. Mcalister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer - a meta-analysis of unconfounded studies. Br J Surg 1998;85:171-8.
19. Vamvakas E, Dzik WH, Blajchman MA. Deleterious effects of transfusion-associated immunomodulation: appraisal of the evidence and recommendations for prevention. In: Vamvakas E, Blajchman M, editors. Immunodmodulatory effects of blood transfusion. Bethesda: American Association of Blood Banks; 1999. p. 253-85.
20. Vamvakas EC, Blajchman MA. Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion [review]. Transfus Med Rev 2000;14:23-33.
21. Vamvakas EC. Multicenter randomized controlled trials in transfusion medicine. Transfus Med Rev 2000;14:137-50.
22. Vamvakas EC, Blajchman MA. Universal WBC reduction: the case for and against [review]. Transfusion 2001;41:691-712.
23. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? [review]. Blood 2001;97:1180-95.
24. Vamvakas EC. Transfusion-related immunomodulation: a debate over the possible deleterious clinical effects of allogeneic blood transfusion. Transfus Alternatives Transfus Med 2002;4:48-52.
25. Vamvakas EC. Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev 2002;16:304-14.
26. Vamvakas EC. Applications of meta-analysis in transfusion medicine. Transfus Alternatives Transfus Med 2003;5:311-8.
27. Fergusson D, Khanna MP, Tinmouth A, Hebert PC. Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Can J Anaesth 2004;51:417-24.
28. Bracey AW, Radovancevic R, Nussmeier NA, et al. Leukocyte-reduced blood in open heart surgery patients: effects on outcome [abstract]. Transfusion 2002;42(Suppl):5S.
29. Boshkov LK, Furnary A, Morris C, et al. Prestorage leukoreduction of red cells in elective cardiac surgery: results of a double blind randomized controlled trial [abstract]. Blood 2004;104(Suppl):112a.
30. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997;34:34-40.
31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
32. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med 2001;20:3625-33.
33. Diversity and heterogeneity [monograph on the Internet]. Oxford: The Cochrane Collaboration; c2002 [accessed 2006 Jun 21]. Available from: http://www.cochrane-net.org/openlearning/HTML/mod13-5.htm